Johnson & Johnson (JNJ) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Johnson & Johnson (JNJ) quarterly earnings & revenue
Johnson & Johnson (JNJ) reported revenue of $24.06B for Q1 2026, up 9.9% year-over-year, with net income of $5.24B and diluted EPS of $2.14.
Over the last four reported quarters, Johnson & Johnson generated $96.36B in revenue and $21.04B in net income.
Johnson & Johnson's next earnings report is scheduled for July 15, 2026 before market open; analysts estimate EPS of $2.83.
Johnson & Johnson quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $24.06B | +9.9% | $5.24B | $2.14 |
| Q4 2025 | $24.56B | +9.1% | $5.12B | $2.10 |
| Q3 2025 | $23.99B | +6.8% | $5.15B | $2.12 |
| Q2 2025 | $23.74B | +5.8% | $5.54B | $2.29 |
| Q1 2025 | $21.89B | +2.4% | $11.00B | $4.54 |
| Q4 2024 | $22.52B | +5.3% | $3.43B | $1.41 |
| Q3 2024 | $22.47B | +5.2% | $2.69B | $1.11 |
| Q2 2024 | $22.45B | +4.3% | $4.69B | $1.93 |
Johnson & Johnson (JNJ) — frequently asked questions
When does Johnson & Johnson (JNJ) report earnings next?
Johnson & Johnson is expected to report earnings on July 15, 2026 before market open. Analysts estimate EPS of $2.83.
What was JNJ's revenue last quarter?
Johnson & Johnson reported revenue of $24.06B in Q1 2026, up 9.9% from the same quarter a year earlier.
What was JNJ's EPS last quarter?
Johnson & Johnson reported diluted EPS of $2.14 in Q1 2026.
Is Johnson & Johnson profitable?
Johnson & Johnson is currently profitable, with $21.04B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK) · Novartis (NVS)